Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

BioNTech begins phase 1 trial for malaria vaccine

December 23, 2022 Medical Communications

BioNTech has announced the start of its new first-in-human phase 1 trial for BNT165b1, a candidate from its programme which …
News

Celltrion submits application for CT-P13 SC to FDA

December 23, 2022 Medical Communications

Celltrion has announced that it has finalised its submission of a biologics license application for the subcutaneous version of a …
News

COVID-19 antiviral treatment shown to speed up recovery in trial

December 23, 2022 Medical Communications

Molnupiravir, made by Merck, Sharp and Dohme (MSD), has been found to reduce the recovery time of COVID-19 patients, however …
News

Treatment for rare, paediatric growth hormone deficiency recommended by NICE for use on the NHS

December 22, 2022 Medical Communications

Walton Oaks, 22 December 2022 – Pfizer Ltd today announces that the National Institute for Health and Care Excellence (NICE) …
News
Press release

AstraZeneca shares two new drug approvals in the EU

December 22, 2022 Medical Communications

On Wednesday, AstraZeneca announced two drug approvals in the European Union (EU). The first being Imfinzi’s approval for the treatment …
News

Everest Medicines and licensing partner Pfizer receive FDA and EMA approval for ulcerative colitis drug

December 22, 2022 Medical Communications

Everest Medicines, a biopharmaceutical company, has announced that its licensing partner, Pfizer, has received acceptance from the FDA for a …
News

New monoclonal antibody for hospitalised COVID-19 patients approved by FDA

December 22, 2022 Medical Communications

The FDA has approved Roche’s monoclonal antibody which treats hospitalised adult patients with COVID-19. The antibody, Actemra, is already approved …
News

Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of Antibody Combination Within 12 Months of Discovery

December 21, 2022 Medical Communications

LONDON, UK, 21st December 2022 — RQ Bio announces that the first of its discovered monoclonal antibodies to prevent COVID-19 …
News
Press release

Kite set to acquire Tmunity Therapeutics

December 21, 2022 Medical Communications

Santa Monica, US-based Kite is set to acquire Philadelphia, US-based Tmunity Therapeutics: a clinical stage, private biotech company. The financial …
News

Two biotech CEOs charged with defrauding investors over investigational HIV drug

December 21, 2022 Medical Communications

Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company …
News

Gambia panel recommends Maiden Pharmaceuticals be held culpable for cough syrup deaths

December 21, 2022 Medical Communications

A parliamentary committee in The Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as they have sold …
News

Tamiflu manufacturers report shortages during high point of flu season

December 21, 2022 Medical Communications

The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high …
News
carlos-muza-hpjsku2uysu-unsplash

ServBlock secures EU funding for pharma manufacturing data space

December 20, 2022 Medical Communications

ServBlock, an Irish start-up, and Irish Manufacturing Research (IMR), have been given EU funding to build a data exchange system …
News

Abbott’s Eterna spinal cord stimulation system given FDA approval

December 20, 2022 Medical Communications

US-based Abbott Laboratories has announced that their Eterna spinal cord stimulation (SCS) system has been given approval by the FDA. …
News

Unison boss states Government has “adamantly refused” to engage in a “proper discussion” on pay ahead of Wednesday’s ambulance strikes

December 19, 2022 Medical Communications

Unison general secretary Christina McAnea has said that Wednesday’s ambulance strikes will go ahead without a “very firm commitment” on …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026